Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?

被引:21
作者
Then, Rudolf L. [1 ]
Sahl, Hans-Georg [1 ]
机构
[1] Univ Bonn, Dept Pharmaceut Microbiol, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany
关键词
Narrow spectrum antibiotics; pathogen-specific therapy; antibiotics; infectious diseases; HELICOBACTER-PYLORI AGENTS; IN-VITRO; DIHYDROOROTATE DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; THIAMINE PYROPHOSPHATE; STRUCTURAL ELUCIDATION; STAPHYLOCOCCUS-AUREUS; BACTERIOPHAGE THERAPY; SELECTIVE-INHIBITION; FABI INHIBITOR;
D O I
10.2174/138161210790361407
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Broad-spectrum antibiotics, directed against conserved bacterial targets, are the mainstay of antibacterial therapy. Increasing resistance, however, demands new strategies. Over time a number of therapeutic concepts have evolved, starting out with the use of polyclonal antisera, which were rapidly replaced by the easier to use antibiotics. Other concepts, such as immunotherapy, radioimmunotherapy, anti-virulence agents, phage therapy and others are under evaluation and often limited in application. In the discovery process of new antibiotics in the pharmaceutical industry quite a number of new agents have emerged, which exhibit a surprisingly high degree of species-specificity. None of them has been considered for development so far. Some examples from the literature which show selectivity for Helicobacter pylori, Pseudomonas aeruginosa, Haemophilus influenzae, Staphylococcus aureus, anaerobes, and others, will be discussed here. It is postulated that there is a room for such agents in future antibacterial therapy, e. g. in difficult to treat infections caused by nonfermenters such as multiresistant P. aerugoinosa, Acinetobacter, Enterobacteriaceae, and S. aureus, including MRSA. Their application would include monotherapy as well as combination therapy with other antibiotics, antivirulence agents or immunotherapy and these possibilities would greatly expand the current anti-infective armamentarium.
引用
收藏
页码:555 / 566
页数:12
相关论文
共 100 条
[1]   A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[2]   Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target;: structural, kinetic and RNAi studies [J].
Arakaki, Tracy L. ;
Buckner, Frederick S. ;
Gillespie, J. Robert ;
Malmquist, Nicholas A. ;
Phillips, Margaret A. ;
Kalyuzhniy, Oleksandr ;
Luft, Joseph R. ;
DeTitta, George T. ;
Verlinde, Christophe L. M. J. ;
Van Voorhis, Wesley C. ;
Hol, Wim G. J. ;
Merritt, Ethan A. .
MOLECULAR MICROBIOLOGY, 2008, 68 (01) :37-50
[3]   Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents:: A novel pro-drug approach to increase exposure [J].
Basarab, Gregory S. ;
Hill, Pamela J. ;
Rastagar, Abdullah ;
Webborn, Peter J. H. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) :4716-4722
[4]   Synthesis and SAR evaluation of oxadiazolopyrazines as selective Haemophilus influenzae antibacterial agents [J].
Beebe, X ;
Nilius, AM ;
Merta, PJ ;
Soni, NB ;
Bui, MH ;
Wagner, R ;
Beutel, BA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3133-3136
[5]   Riboswitches as antibacterial drug targets [J].
Blount, Kenneth F. ;
Breaker, Ronald R. .
NATURE BIOTECHNOLOGY, 2006, 24 (12) :1558-1564
[6]   Synthetic dihydropacidamycin antibiotics: A modified spectrum of activity for the pacidamycin class [J].
Boojamra, CG ;
Lemoine, RC ;
Blais, J ;
Vernier, NG ;
Stein, KA ;
Magon, A ;
Chamberland, S ;
Hecker, SJ ;
Lee, VJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3305-3309
[7]   How many modes of action should an antibiotic have? [J].
Broetz-Oesterhelt, Heike ;
Brunner, Nina A. .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) :564-573
[8]   Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformans [J].
Bryan, Ruth A. ;
Huang, Xianchun ;
Morgenstern, Alfred ;
Bruchertseifer, Frank ;
Casadevall, Arturo ;
Dadachova, Ekaterina .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2232-2235
[9]  
Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128
[10]   Bacteriophage Therapy and the Mutant Selection Window [J].
Cairns, Benjamin J. ;
Payne, Robert J. H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) :4344-4350